Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Carpentier

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
Bulletin Du Cancer|May 13, 2005
[New therapeutic approaches in glioblastomas]Antoine F Carpentier
Medecine Sciences : M/S|January 11, 2005
[Cancer immunotherapy with CpG-ODN]Antoine F Carpentier
La Revue Du Praticien|June 14, 2014
[Chemotherapy and targeted therapies in the management of brain metastases]Antoine F Carpentier
Revue Neurologique|April 1, 2005
[New therapeutic approaches in glioblastomas]A F Carpentier
Presse Medicale (Paris, France : 1983)|January 20, 1999
[New therapeutic agents in the management of multiple sclerosis]G Besson, F Carpentier
Current Opinion in Neurology|October 13, 2022
Neurological adverse events of immune checkpoint blockade: from pathophysiology to treatmentStefania Cuzzubbo, Antoine F Carpentier
Advances in Experimental Medicine and Biology|May 29, 2012
Immunotherapeutic approach with oligodeoxynucleotides containing CpG motifs (CpG-ODN) in malignant gliomaRenata Ursu, Antoine F Carpentier
Cancers|April 3, 2021
Applications of Melanin and Melanin-Like Nanoparticles in Cancer Therapy: A Review of Recent AdvancesStefania Cuzzubbo, Antoine F Carpentier
Current Opinion in Oncology|September 22, 2006
Recent advances in immunotherapy for human gliomaAntoine F Carpentier, Yuxia Meng
La Revue Du Praticien|December 5, 2018
Glioblastomas: what’s new?Stefania Cuzzubbo, Antoine F Carpentier
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
Bulletin Du Cancer|May 13, 2005
[New therapeutic approaches in glioblastomas]Antoine F Carpentier
Medecine Sciences : M/S|January 11, 2005
[Cancer immunotherapy with CpG-ODN]Antoine F Carpentier
La Revue Du Praticien|June 14, 2014
[Chemotherapy and targeted therapies in the management of brain metastases]Antoine F Carpentier
Revue Neurologique|April 1, 2005
[New therapeutic approaches in glioblastomas]A F Carpentier
Presse Medicale (Paris, France : 1983)|January 20, 1999
[New therapeutic agents in the management of multiple sclerosis]G Besson, F Carpentier
Current Opinion in Neurology|October 13, 2022
Neurological adverse events of immune checkpoint blockade: from pathophysiology to treatmentStefania Cuzzubbo, Antoine F Carpentier
Advances in Experimental Medicine and Biology|May 29, 2012
Immunotherapeutic approach with oligodeoxynucleotides containing CpG motifs (CpG-ODN) in malignant gliomaRenata Ursu, Antoine F Carpentier
Cancers|April 3, 2021
Applications of Melanin and Melanin-Like Nanoparticles in Cancer Therapy: A Review of Recent AdvancesStefania Cuzzubbo, Antoine F Carpentier
Current Opinion in Oncology|September 22, 2006
Recent advances in immunotherapy for human gliomaAntoine F Carpentier, Yuxia Meng
La Revue Du Praticien|December 5, 2018
Glioblastomas: what’s new?Stefania Cuzzubbo, Antoine F Carpentier
Pageof 21